Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Sanofi
FDA
clinical trials
hemophilia A
efanesoctocog alfa
Roche
Hemlibra
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Roche’s Tecentriq to be filed for early-stage liver cancer
Pharmaphorum
Thu, 01/19/23 - 09:41 am
Roche
Tecentriq
Avastin
clinical trials
liver cancer
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Fierce Pharma
Mon, 01/16/23 - 11:16 am
Merck
Keytruda
Roche
cancer
oncology
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
pharma stocks
Amgen
BeiGene
Bristol Myers Squibb
Gilead Sciences
Lantheus Holdings
Madrigal Pharmaceuticals
Merck
Moderna Therapeutics
Novo Nordisk
Prometheus Biosciences
Roche
Roche searches for pharma chief Anderson's successor from within: chairman
Fierce Pharma
Fri, 01/13/23 - 11:13 am
Roche
Bill Anderson
Three TIGIT players look to surprise in 2023
EP Vantage
Fri, 01/13/23 - 10:06 am
anti-TIGIT
Roche
Merck
Gilead Sciences
Arcus Biosciences
JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals
Fierce Pharma
Tue, 01/10/23 - 10:50 am
JPMHC 2023
Takeda
vaccines
Roche
GSK
Bayer
Merck
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Fierce Biotech
Mon, 01/9/23 - 10:39 am
Kronos Bio
biobucks
AML
Roche
Genentech
small molecule drugs
drug discovery
FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate
Endpoints
Sun, 01/8/23 - 09:59 pm
FDA
priority review
Pfizer
Prevnar 20
vaccines
Roche
bispecific antibodies
glofitamab
lymphoma
Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal
Fierce Biotech
Fri, 01/6/23 - 09:33 am
Roche
Genentech
Nimble Therapeutics
biobucks
drug discovery
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Pfizer
Merck
JNJ
Novartis
AbbVie
Roche
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics
Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma
Fierce Pharma
Wed, 12/28/22 - 08:32 pm
Roche
FDA
Lunsumio
gene therapy
follicular lymphoma
Roche takes over development of Biogen-partnered lymphoma drug
BioPharma Dive
Tue, 12/20/22 - 11:11 am
Roche
Biogen
lymphoma
glofitamab
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
AstraZeneca
Daiichi Sankyo
Pfizer
Roche
CSL
uniQure
Novo Nordisk
Eli Lilly
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
Roche wins earlier-than-expected approval for blockbuster Tecentriq in rare soft tissue cancer
Endpoints
Tue, 12/13/22 - 11:50 pm
Roche
Tecentriq
FDA
soft tissue cancer
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »